- Home
- SLS vs NMS Comparison
SLS vs NMS Comparison
Compare SLS & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- NMS
- Stock Information
- Founded
- SLS 2012
- NMS 1993
- Country
- SLS United States
- NMS United States
- Employees
- SLS N/A
- NMS N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- NMS Finance Companies
- Sector
- SLS Health Care
- NMS Finance
- Exchange
- SLS Nasdaq
- NMS Nasdaq
- Market Cap
- SLS 75.3M
- NMS 76.2M
- IPO Year
- SLS N/A
- NMS N/A
- Fundamental
- Price
- SLS $1.32
- NMS $13.16
- Analyst Decision
- SLS Buy
- NMS
- Analyst Count
- SLS 1
- NMS 0
- Target Price
- SLS $3.00
- NMS N/A
- AVG Volume (30 Days)
- SLS 753.9K
- NMS 12.0K
- Earning Date
- SLS 11-13-2024
- NMS 01-01-0001
- Dividend Yield
- SLS N/A
- NMS 4.11%
- EPS Growth
- SLS N/A
- NMS N/A
- EPS
- SLS N/A
- NMS N/A
- Revenue
- SLS N/A
- NMS N/A
- Revenue This Year
- SLS N/A
- NMS N/A
- Revenue Next Year
- SLS N/A
- NMS N/A
- P/E Ratio
- SLS N/A
- NMS N/A
- Revenue Growth
- SLS N/A
- NMS N/A
- 52 Week Low
- SLS $0.50
- NMS $9.21
- 52 Week High
- SLS $1.72
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- SLS 60.02
- NMS 50.18
- Support Level
- SLS $1.22
- NMS $12.95
- Resistance Level
- SLS $1.39
- NMS $13.71
- Average True Range (ATR)
- SLS 0.08
- NMS 0.26
- MACD
- SLS 0.02
- NMS 0.00
- Stochastic Oscillator
- SLS 72.00
- NMS 25.93
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.